Asset
Avrukibart
Oruka Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07449702 | phase2 | recruiting | 2026-02-23 | 2030-05-01 | Oruka Therapeutics, Inc. | An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis |
| NCT07290569 | phase2 | active_not_recruiting | 2025-12-03 | 2027-06-01 | Oruka Therapeutics, Inc. | Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis |
| NCT06698939 | phase1 | completed | 2024-12-19 | 2026-03-13 | Oruka Therapeutics, Inc. | ORKA-001 in Healthy Volunteers |
FDA applications (0)
This company has no applications containing this asset.